- Previous Close
0.6860 - Open
0.6850 - Bid 0.6366 x 200
- Ask 0.6922 x 200
- Day's Range
0.6400 - 0.7067 - 52 Week Range
0.6400 - 2.4500 - Volume
241,542 - Avg. Volume
1,227,283 - Market Cap (intraday)
17.139M - Beta (5Y Monthly) 2.07
- PE Ratio (TTM)
-- - EPS (TTM)
-0.6000 - Earnings Date Mar 11, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacturing, and marketing of proprietary life support technologies in Israel. Its lead product candidate is INSPIRA ART system, a form of life support designed to provide adaptive blood oxygenation while continuously measuring the patient's blood parameters in real-time. The company has a strategic collaboration with Westchester Medical Center to evaluate INSPIRA ART100 functionality and performance in clinical scenarios. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. Inspira Technologies Oxy B.H.N. Ltd. was incorporated in 2018 and is headquartered in Ra'anana, Israel.
inspira-technologies.comRecent News: IINN
View MorePerformance Overview: IINN
Trailing total returns as of 3/31/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: IINN
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: IINN
View MoreValuation Measures
Market Cap
17.57M
Enterprise Value
12.45M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
4.07
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-81.03%
Return on Equity (ttm)
-219.74%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-11.05M
Diluted EPS (ttm)
-0.6000
Balance Sheet and Cash Flow
Total Cash (mrq)
7.36M
Total Debt/Equity (mrq)
15.30%
Levered Free Cash Flow (ttm)
-5.34M